Albany, NY -- (SBWIRE) -- 05/15/2015 -- According to a new market report published by Transparency Market Research "Auto-injectors Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020", the global auto-injectors market was valued at USD 665.0 million in 2013 and is expected to grow at a CAGR of 18.6% from 2014 to 2020, to reach USD 2,503.4 million in 2020.

The injectable devices market has witnessed a paradigm shift from traditional devices administered by skilled personnel to self-injection devices. Auto-injectors, initially used as accessories, have evolved into life saving medical products and are currently a major medical device segment. Auto-injectors have emerged as one of the fastest growing drug administration solutions, driven by factors such as allowance for at-home drug administration, reduction in the number of hospital visits (thereby reducing the cost of health care), rise in prevalence of anaphylaxis and others. Acceptance of auto-injectors under insurance reimbursement by governments is further encouraging patients to switch from manual injections and prefilled syringes to auto-injectors, thereby boosting the market for auto-injectors.

For more information, Tables, figures and Segmentation, visit:
http://www.transparencymarketresearch.com/global-auto-injectors-market.html

Auto-injectors used for the management of anaphylaxis dominated the market in 2013, with a share of around 95%. Rising prevalence of anaphylaxis in developed economies coupled with the corresponding purchasing parity in these nations are the major factors driving the market for anaphylaxis auto-injectors. Additionally, major players such as Mylan, Inc. and Ypsomed AG are spreading awareness about the use and effectiveness of auto-injectors. These companies employ other marketing strategies such as providing free auto-injectors for use in schools, and offering $0 Co-Pay Card with auto-injectors. This increases demand for auto-injectors among patients, which in turn drives the growth of the auto-injectors market.

Geographically, North America held the largest share of 70% of the auto-injectors market in 2013. High prevalence of anaphylaxis and multiple sclerosis, availability of favorable reimbursement options and awareness about novel medical devices are the major factors that drive the auto-injectors market in North America. However, Asia Pacific is estimated to be the fastest-growing market for auto-injectors during the forecast period. High prevalence of anaphylaxis in New Zealand and Australia is the major factor that is likely to fuel the growth of the auto-injectors market during the forecast period in the region. Moreover, introduction of novel reimbursement policy in New Zealand by the Pharmaceutical Management Agency (PHARMAC) in February 2013, which included Biogen Idec's Avonex Pen auto-injector in the reimbursement devices list, is one of the major factors that would contribute significantly to the growth of the auto-injectors market in Asia Pacific.

Requesting for sample :
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4199

Major players operating in the global auto-injectors market include Antares Pharma, Inc., Becton, Dickinson and Company, Biogen Idec, Inc., Mylan, Inc., Novartis International AG, Pfizer, Inc., Sanofi, Scandinavian Health Limited (SHL) Group, Unilife Corporation, and Ypsomed Holdings AG. These players engage in product innovation and geographical expansion strategies to increase market shares and to strengthen their positions globally.

The global auto-injectors market has been segmented into the following categories:

Global Auto-Injectors Market, by Product Type
- Prefilled (Disposable) Auto-injectors
- Fillable (Reusable) Auto-injectors

Global Auto- Injectors Market, by Therapeutic Application
- Anaphylaxis
- Multiple Sclerosis
- Rheumatoid Arthritis
- Others

Global Auto-Injectors Market, by Product Type
- Standardized Auto-injectors
- Customized Auto-injectors

Global Auto-Injectors Market, by Geography
- North America
- Europe
- Asia Pacific
- Rest of the World (RoW)

About Transparency Market Research
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.